Clinical Trial Update: A Study on Intima Media Thickness (IMT) in Middle-aged Subjects

View source ↗

Summary

AstraZeneca-sponsored trial evaluating the effect of a treatment on carotid intima-media thickness in middle-aged adults with atherosclerosis; the trial has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: AstraZeneca | Conditions: Atherosclerosis | Status: COMPLETED